Darren Barton Selected Research

Strontium-89

1/2017	Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747).
4/2016	Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial.
1/2016	TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Darren Barton Research Topics

Disease

3	Liver Diseases (Liver Disease) 10/2019 - 01/2017
3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2016
3	Alcoholic Fatty Liver 02/2016 - 11/2013
2	Pathologic Constriction (Stenosis) 01/2024 - 01/2020
2	Wounds and Injuries (Trauma) 01/2023 - 01/2021
2	Infections 01/2021 - 03/2016
2	Fibrosis (Cirrhosis) 01/2018 - 02/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 01/2017
2	Insulin Resistance 02/2016 - 02/2016
2	Type 2 Diabetes Mellitus (MODY) 02/2016 - 11/2013
1	Thrombosis (Thrombus) 01/2024
1	Brain Death (Brain Dead) 01/2024
1	Burns 01/2023
1	Autoimmune Hepatitis 10/2019
1	Myocardial Infarction 01/2018
1	Sepsis (Septicemia) 01/2018
1	Brain Diseases (Brain Disorder) 01/2018
1	Ascites 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2017
1	Neoplasms (Cancer) 04/2017
1	Sclerosing Cholangitis 01/2017
1	Fatty Liver 02/2016
1	Constipation 02/2016
1	Overweight 02/2016
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2016
1	Pain (Aches) 01/2016
1	Weight Loss (Weight Reduction) 11/2013

Drug/Important Bio-Agent (IBA)

3	Zoledronic Acid (Zometa)FDA Link 01/2017 - 01/2016
3	Strontium-89IBA 01/2017 - 01/2016
3	Liraglutide FDA Link 02/2016 - 11/2013
3	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2016 - 11/2013
2	Docetaxel (Taxotere)FDA Link 01/2017 - 04/2016
2	EnzymesIBA 02/2016 - 11/2013
1	dicarboxydine (DCD)IBA 01/2024
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2023
1	AndrogensIBA 01/2021
1	Dehydroepiandrosterone (DHEA)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018
1	OsteopontinIBA 04/2017
1	timolumabIBA 01/2017
1	Scavenger Receptors (Scavenger Receptor)IBA 03/2016
1	ITX-5061IBA 03/2016
1	Insulin (Novolin)FDA Link 02/2016
1	LipidsIBA 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2016

Therapy/Procedure

5	Therapeutics 10/2019 - 01/2016
3	Transplantation 01/2024 - 03/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2016
1	Resuscitation 01/2021
1	Gamma Cameras (Gamma Camera) 10/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2019
1	Liver Transplantation 03/2016
1	Subcutaneous Injections 02/2016
1	Castration 01/2016